Researchers Discover Novel Nanoparticles in Blood With Potential to Transform Cancer Diagnosis (IMAGE)
Caption
Researchers at Icahn Mount Sinai found a new class of RNA in blood nanoparticles, potentially paving the way for less invasive cancer diagnosis. They used next-generation RNA sequencing and other innovative tools to develop a cost-effective liquid biopsy test to isolate and identify these novel RNA types.
Credit
Laboratory of Navneet Dogra, PhD, Icahn Mount Sinai.
Usage Restrictions
May be used only in the context of this news.
License
Original content